Avanos Medical (AVNS) EPS (Diluted) Growth (3y) (2016 - 2026)
Avanos Medical (AVNS) EPS (Diluted) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 175.52 Bn | 6.27 Bn | -6.43% |
| 2 | Stryker | 128.98 Bn | 126.10 Bn | 3.81 Bn | 7.66% |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 68.36 Bn | 66.91 Bn | 3.61 Bn | 62.91% |
| 5 | Edwards Lifesciences | 47.70 Bn | 44.03 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.67 Bn | 27.55 Bn | 750.30 Mn | 63.42% |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 29.56% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 30.57% |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn | -11.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.45% |
| Dec 31, 2024 | 76.90% |
| Sep 30, 2024 | 63.97% |
| Jun 30, 2024 | -27.41% |
| Mar 31, 2024 | 44.46% |
| Dec 31, 2023 | 78.13% |
| Sep 30, 2023 | -35.24% |
| Jun 30, 2023 | -179.01% |
| Mar 31, 2023 | 26.13% |
| Dec 31, 2021 | -273.06% |
| Jun 30, 2021 | 3.94% |
| Mar 31, 2021 | -31.24% |
| Dec 31, 2020 | -54.52% |
| Sep 30, 2020 | -10.68% |
| Jun 30, 2020 | -28.14% |
| Mar 31, 2020 | -49.10% |
| Dec 31, 2018 | -88.67% |
| Jun 30, 2018 | 60.40% |
| Mar 31, 2018 | 13.07% |
| Dec 31, 2017 | 139.67% |